Clinical Trials Sponsored by MapLight Therapeutics
Total 6329 results
-
Arxx TherapeuticsRecruitingHealthy Volunteers | Mild to Moderate PsoriasisUnited Kingdom
-
Fate TherapeuticsRecruitingRelapsed/Refractory B-Cell LymphomaUnited States
-
Protara TherapeuticsRecruitingNon-muscle Invasive Bladder CancerUnited States, Ukraine
-
Kyverna TherapeuticsRecruitingLupus Nephritis | Lupus Nephritis - World Health Organization (WHO) Class III | Lupus Nephritis - WHO Class IVUnited States
-
Sapience TherapeuticsRecruitingHepatocellular Carcinoma | Pancreatic Cancer | Ovarian Cancer | Cholangiocarcinoma | Triple Negative Breast Cancer | Metastatic Melanoma | Colon Cancer | Synovial Sarcoma | Breast Cancer Metastatic | Metastatic Colon Cancer | Melanoma Stage IV | Melanoma Recurrent | TNBC - Triple-Negative Breast Cancer | NSCLC, Metastatic and other conditionsUnited States
-
Onward TherapeuticsRecruitingSolid Tumor | Hematological MalignancyFrance
-
Iterion TherapeuticsRecruitingAdvanced Hepatocellular CarcinomaUnited States, Canada
-
Corcept TherapeuticsRecruitingDiabetes Mellitus, Type 2 | HypercortisolismUnited States
-
AUG TherapeuticsRecruitingLeukocyte Adhesion DeficiencyUnited States
-
Hemerion TherapeuticsRecruitingPrimary GlioblastomaUnited States
-
Elicio TherapeuticsRecruitingColorectal Cancer | Pancreatic Ductal Adenocarcinoma | KRAS G12D | KRAS G12R | NRAS G12D | NRAS G12R | KRAS G12V | KRAS G12C | KRAS G12A | KRAS G12S | KRAS G13D | NRAS G12V | NRAS G12C | NRAS G12SUnited States
-
NovelMed TherapeuticsNot yet recruitingaHUS - Atypical Hemolytic Uremic Syndrome
-
GV20 TherapeuticsRecruitingCholangiocarcinoma | Non-small Cell Lung Cancer | Endometrial Carcinoma | Head and Neck Carcinoma | Cutaneous Melanoma | Solid Tumor, Adult | Refractory Cancer | Adenocarcinoma of the Rectum | Bladder Urothelial Carcinoma | Adenocarcinoma of the ColonUnited States
-
Perspective TherapeuticsRecruitingMetastatic Melanoma | Melanoma (Skin) | Mucosal Melanoma | Melanoma Stage IV | Melanoma Stage III | Melanoma, UvealUnited States
-
Enliven TherapeuticsRecruitingHER2-positive Metastatic Breast Cancer | HER2 Gene Mutation | HER2 Mutant Non-small Cell Lung Cancer | HER2 AmplificationSpain, United States, Korea, Republic of, Taiwan, Italy, Australia, France
-
Prelude TherapeuticsRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Non-small Cell Lung Cancers | SMARCA4 Gene MutationUnited States, France, Spain, Singapore, Netherlands
-
PYC TherapeuticsRecruitingRetinitis Pigmentosa | Eye Diseases, Hereditary | Retinal Dystrophies | Retinal Dystrophy Rod | Retinal Dystrophy Rod ProgressiveUnited States, Australia
-
Immunitas TherapeuticsRecruitingFollicular Lymphoma | Colorectal Cancer | Hodgkin Lymphoma | Esophageal Cancer | Small Bowel Cancer | Burkitt Lymphoma | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Diffuse Large B Cell Lymphoma | Head and Neck Squamous Cell Carcinoma | Hormone Receptor Positive Breast Carcinoma | Cutaneous...United States
-
Aerovate TherapeuticsRecruitingPulmonary Arterial HypertensionUnited States, Belgium, Italy, Spain, Australia, Canada, China, Singapore, France, United Kingdom, Latvia, Mexico, Argentina, Israel, South Africa, Chile, Poland, Germany, Portugal, Colombia
-
Corcept TherapeuticsRecruitingNon-alcoholic Steatohepatitis (NASH)United States
-
Phoenicis TherapeuticsNot yet recruitingDystrophic Epidermolysis BullosaUnited States
-
Mersana TherapeuticsRecruitingHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Non-Small Cell Lung Cancer | HER2-positive Colorectal Cancer | HER2-positive Tumors | HER2 Low Breast CancerUnited States
-
Karuna TherapeuticsRecruitingPsychosis Associated With Alzheimer's DiseaseUnited States, Spain, Slovakia, Bulgaria, France, Czechia, Italy, Serbia, Germany, Croatia
-
Lexeo TherapeuticsRecruitingFriedreich Ataxia | Cardiomyopathy, SecondaryUnited States, Canada
-
Phanes TherapeuticsRecruitingNon Small Cell Lung Cancer | Pancreatic Ductal AdenocarcinomaUnited States
-
Tallac TherapeuticsRecruitingAdvanced or Metastatic Solid TumorsUnited States, Australia
-
PTC TherapeuticsRecruitingA Study to Evaluate the Safety and Efficacy of PTC518 in Participants With Huntington's Disease (HD)Huntington DiseaseUnited States, Austria, Spain, United Kingdom, Australia, France, Germany, Netherlands, Italy, New Zealand, Canada
-
Lyra TherapeuticsRecruitingChronic Sinusitis | Chronic Rhinosinusitis (Diagnosis)United States, Poland, Bulgaria, Belgium, Germany, Hungary
-
United TherapeuticsRecruitingIdiopathic Pulmonary Fibrosis | Interstitial Lung DiseaseTaiwan, Belgium, Spain, Korea, Republic of, Germany, Australia, Chile, Denmark, France, Mexico, Israel, Italy, Netherlands, Argentina, New Zealand, Peru
-
Stemirna TherapeuticsRecruitingSolid TumorAustralia, Austria
-
iTeos TherapeuticsRecruitingSolid Tumor, AdultBelgium, United Kingdom
-
Corcept TherapeuticsRecruitingNonalcoholic Steatohepatitis (NASH)United States
-
Alterity TherapeuticsRecruitingMultiple System AtrophyUnited States, Australia, New Zealand, United Kingdom, Italy, France, Austria
-
Protara TherapeuticsRecruitingNon-muscle Invasive Bladder CancerUnited States, Moldova, Republic of, Romania, Ukraine
-
Plus TherapeuticsRecruitingLeptomeningeal MetastasisUnited States
-
Aspa TherapeuticsRecruitingCanavan DiseaseUnited States
-
General TherapeuticsNot yet recruitingOsteoarthritis, Knee
-
Aprea TherapeuticsRecruitingAdvanced Solid TumorUnited States
-
ProQR TherapeuticsRecruitingEye Diseases | Neurologic Manifestations | Retinal Degeneration | Retinal Dystrophies | Sensation Disorders | Vision Disorders | Blindness | Leber Congenital Amaurosis | Leber Congenital Amaurosis 10 | Retinal Disease | Eye Disorders CongenitalBelgium, Brazil, Canada, Germany, Italy, Netherlands, United Kingdom
-
Kamau TherapeuticsRecruitingSickle Cell DiseaseUnited States
-
Cartesian TherapeuticsRecruiting
-
Amicus TherapeuticsRecruitingGlycogen Storage Disease Type II Infantile OnsetUnited States, Taiwan, France, Germany, Italy, United Kingdom
-
AKARI TherapeuticsRecruitingThrombotic MicroangiopathiesUnited States, United Kingdom, Poland
-
Catapult TherapeuticsRecruitingLymphocytic Leukemia, Chronic | SLLUnited States, Spain
-
MitoImmune TherapeuticsRecruitingHead and Neck Squamous Cell Carcinoma | Oral MucositisKorea, Republic of, United States
-
Aligos TherapeuticsRecruitingChronic Hepatitis BHong Kong, China, United Kingdom, Moldova, Republic of, New Zealand, Australia, Mauritius
-
Lykos TherapeuticsNot yet recruitingBinge-Eating Disorder | Anorexia Nervosa Restricting Type
-
ImCheck TherapeuticsRecruitingHematopoietic/Lymphoid Cancer | Solid Tumor, AdultFrance, Belgium, United States, Germany, Spain, United Kingdom
-
Cartesian TherapeuticsRecruitingMyasthenia Gravis, GeneralizedUnited States, Canada
-
Dragonfly TherapeuticsRecruitingSolid Tumor, AdultUnited States, Denmark, Netherlands, Belgium, France